Seroatlas · Human Serome Atlas

MIR7-3HG

Putative uncharacterized protein encoded by MIR7-3HG

Also known as: PGSF1_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: Q8N6C7
Gene: MIR7-3HG
Canonical length: 128 aa

OverviewNCBI Gene

No narrative summary is available for MIR7-3HG in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

128 residues, UniProt reviewed canonical sequence.

>Q8N6C7|MIR7-3HG
     1  MPGMRLVCRL AHGHFPRKGQ RRRSLTVWKA ETSRADCLGA PNIRTAPLGR SEKRTAICFS
    61  TGAQDSSQRA PFRLQNPGQL LQLGMHSLHL HPELPTTDPA FFCKLHFIKG NDPYCLTISH
   121  VKSVLTFS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MIR7-3HG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Unknown
Secreted: No
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.61

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MIR7-3HG as an antibody target. Whether an autoantibody or antibody against MIR7-3HG could matter depends on whether native MIR7-3HG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MIR7-3HG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MIR7-3HG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...